Cargando…

Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection

BACKGROUND: Acute and chronic hepatitis E have been associated with high mortality and development of cirrhosis, particularly in solid-organ recipients and patients infected by human immunodeficiency virus. However, data regarding the epidemiology of hepatitis E in special populations is still limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riveiro-Barciela, Mar, Buti, María, Homs, María, Campos-Varela, Isabel, Cantarell, Carmen, Crespo, Manuel, Castells, Lluís, Tabernero, David, Quer, Josep, Esteban, Rafael, Rodriguez-Frías, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113416/ https://www.ncbi.nlm.nih.gov/pubmed/25068388 http://dx.doi.org/10.1371/journal.pone.0103028

Ejemplares similares

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
por: Homs, Maria, et al.
Publicado: (2016)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
por: Caballero, Andrea, et al.
Publicado: (2015)

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
por: Casillas, Rosario, et al.
Publicado: (2018)

Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution
por: Homs, Maria, et al.
Publicado: (2014)

Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection
por: Godoy, Cristina, et al.
Publicado: (2019)

Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome
por: Homs, Maria, et al.
Publicado: (2011)

Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy
por: González, Carolina, et al.
Publicado: (2018)

Long-term efficacy and safety of nucleos(t)ides analogues in patients with chronic hepatitis B
por: Roade, Luisa, et al.
Publicado: (2021)

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient
por: Gregori, Josep, et al.
Publicado: (2022)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
por: García-García, Selene, et al.
Publicado: (2022)

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
por: Álvarez-López, Patricia, et al.
Publicado: (2020)

Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up
por: Cortese, Maria Francesca, et al.
Publicado: (2022)

Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
por: Cortese, Maria Francesca, et al.
Publicado: (2021)

Conservation and variability of hepatitis B core at different chronic hepatitis stages
por: Yll, Marçal, et al.
Publicado: (2020)

Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020
por: Bes, Marta, et al.
Publicado: (2022)

Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
por: Garcia-Garcia, Selene, et al.
Publicado: (2021)

ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype
por: Roade, Luisa, et al.
Publicado: (2022)

New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
por: Quer, Josep, et al.
Publicado: (2010)

Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
por: Buti, Maria, et al.
Publicado: (2021)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
por: Roade, Luisa, et al.
Publicado: (2023)

Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
por: Pacin-Ruiz, Beatriz, et al.
Publicado: (2022)

Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
por: Palom, Adriana, et al.
Publicado: (2022)

Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome
por: Rodriguez-Frías, Francisco, et al.
Publicado: (2012)

An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
por: Riveiro-Barciela, Mar, et al.
Publicado: (2020)

LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona
por: Barreira Díaz, Ana, et al.
Publicado: (2022)

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
por: Perales, Celia, et al.
Publicado: (2018)

Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19
por: Vargas‐Accarino, Elena, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021)

Utility of the Cobas(®) Plasma Separation Card as a Sample Collection Device for Serological and Virological Diagnosis of Hepatitis C Virus Infection
por: Velásquez-Orozco, Fernando, et al.
Publicado: (2021)

Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management
por: Grau-López, Lara, et al.
Publicado: (2021)

Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
por: Riveiro-Barciela, Mar, et al.
Publicado: (2021)

Specific Plasma MicroRNA Signatures Underlying the Clinical Outcomes of Hepatitis E Virus Infection
por: Costafreda, Maria I., et al.
Publicado: (2023)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
por: Riveiro-Barciela, Mar, et al.
Publicado: (2023)

New real-time-PCR method to identify single point mutations in hepatitis C virus
por: Chen, Qian, et al.
Publicado: (2016)

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing
por: Nieto-Aponte, Leonardo, et al.
Publicado: (2017)

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?
por: Bermejo, Sheila, et al.
Publicado: (2022)

Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
por: Soria, María Eugenia, et al.
Publicado: (2018)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021)

Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing
por: Llorens-Revull, Meritxell, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igfumpg6jmdspo7tr7okupc70k